The European Union is ready to help pharmaceutical companies expand production of coronavirus vaccines and eliminate distribution “bottlenecks,” the Supreme Health Authority said Saturday.
Health commissioner Stella Kyriakides told Deutsche Presse DPA that the delay in launching the approved vaccine was not due to EU plans, but to lack of production capacity.
“The bottleneck at this point is not the order volume, but the lack of global production capacity,” she said in a comment from the office.
Kyriakides said Brussels has provided € 100 million to the German company BioNTech, which developed the giant US Pfizer and vaccines to help build production capacity.
And she said Brock is ready to do more for Pfizer-BioNTech and other vaccine candidates as the vaccination campaign goes into full swing.
“The situation will improve over time,” she promised. A week after vaccination began at a very different pace among EU member states.
“We have been negotiating additional vaccine doses from BioNTech for a long time and are ready to help expand our production capacity.
“The other manufacturers we have contracted with are on the verge of being approved by the EU.”
The European Medicines Agency, which advises the European Commission, approved the Pfizer-BioNTech vaccine on 21 December.
However, until January 6, it is not expected to determine potential alternatives from the US company Moderna.
And we are waiting for more data on candidates from AstraZeneca and Oxford University, which have already been approved in the UK.
However, Kyriakides argued that Europe was not behind in a joint procurement program backed by 27 member states.
“If all vaccine candidates are approved, 450 million Europeans and all of their neighbors will have access to more than 2 billion vaccines in Europe,” she said.
“And that’s all. Europe can be the fastest to escape from this crisis.”
Follow the latest news about the outbreak of coronavirus (COVID-19)
© 2021 AFP
Quote: EU is ready to support the expansion of vaccine production (January 2, 2021) January 3, 2021 https://medicalxpress.com/news/2021-01-eu-ready-vaccine-production Obtained from .html
This document is subject to copyright. No part may be reproduced without written permission, except for fair transactions for personal investigation or research purposes. The content is provided for informational purposes only.